---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-23-000682"
form_type: "8-K"
ticker: "STEX"
cik: "0001530766"
company_name: "Streamex Corp."
filed_at: "2023-06-30T23:59:59+00:00"
generated_at: "2026-06-13T13:55:20.723493+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# BioSig subsidiary raises $1.71M in private placement; parent retains 87.5% ownership

## Summary
- BioSig AI Sciences sold 1,710,000 shares to accredited investors at $1.00/share, raising $1.71M.
- Before the placement BioSig owned 100% of BioSig AI; after closing it holds about 87.5%.
- Laidlaw & Co (UK) Ltd received a warrant to buy 90,000 shares at $1.00, exercisable for 5 years.
- Shares and Laidlaw warrant issued under Section 4(a)(2) and Regulation D exemption.

## SEC filing metadata
- accession: 0001185185-23-000682
- form_type: 8-K
- ticker: STEX
- cik: 0001530766
- company_name: Streamex Corp.
- filed_at: 2023-06-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000682/0001185185-23-000682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000682/biosig20230630_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-23-000682
- JSON: https://secwatch.observer/filing/0001185185-23-000682.json
- Plain text: https://secwatch.observer/filing/0001185185-23-000682.txt

## Key facts
- Material Agreements
  Streamex Corp. entered into Securities Purchase Agreement with certain accredited investors valued at $1,710,000 (effective 2023-06-30).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain accredited investors
  - Value: $1,710,000
  - Effective: 2023-06-30
  source text: On June 30, 2023, BioSig AI Sciences, Inc., f/k/a NeuroClear Technologies Inc. (“BioSig AI”), a subsidiary of BioSig Technologies, Inc. (“BioSig”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited investors (the “Investors”), pursuant to which BioSig AI agreed to sell an aggregate of 1,710,000 shares (the “Shares”) of BioSig AI’s common stock, par value $0.001 per share (the “Common Stock”) for an aggregate purchase price of $1,710,000 (the “BioSig AI Private Placement”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1530766/000118518523000682/0001185185-23-000682-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.